CN104906274A - 治疗冠心病的中药 - Google Patents
治疗冠心病的中药 Download PDFInfo
- Publication number
- CN104906274A CN104906274A CN201510330836.2A CN201510330836A CN104906274A CN 104906274 A CN104906274 A CN 104906274A CN 201510330836 A CN201510330836 A CN 201510330836A CN 104906274 A CN104906274 A CN 104906274A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- coronary heart
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 39
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 239000012567 medical material Substances 0.000 claims description 2
- 229940100691 oral capsule Drugs 0.000 claims description 2
- 229940042126 oral powder Drugs 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 2
- 239000008280 blood Substances 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 16
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 206010008479 Chest Pain Diseases 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 8
- 206010033557 Palpitations Diseases 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 241000721047 Danaus plexippus Species 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 208000010125 myocardial infarction Diseases 0.000 abstract description 3
- 244000124209 Crocus sativus Species 0.000 abstract 2
- 235000015655 Crocus sativus Nutrition 0.000 abstract 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 240000005373 Panax quinquefolius Species 0.000 abstract 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000002216 heart Anatomy 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 9
- 238000011084 recovery Methods 0.000 description 8
- 244000153234 Hibiscus abelmoschus Species 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 208000031225 myocardial ischemia Diseases 0.000 description 5
- 210000000115 thoracic cavity Anatomy 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 239000007902 hard capsule Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 206010061216 Infarction Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000001562 sternum Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003683 cardiac damage Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 208000013210 hematogenous Diseases 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940114657 nitroglycerin 0.5 mg Drugs 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗冠心病的中药,其特征是按下述药材配方制成:三七15~25份、丹参15~25份、藏红花15~25份、人工麝香10~20份、制首乌5~15份、刺五加5~15份、酸枣仁5~15份、当归5~15份、柏子仁5~15份、白芍5~15份、西洋参5~15份、冰片2~8份。本发明用于冠心病、心绞痛,早期心梗,心悸、胸闷等症;可滋阴补肾,益气养血,活血化瘀,理气止痛;方中以西洋参为君,麝香为臣,君臣结合,具有振奋根基,固本扶元的作用;丹参为佐药,藏红花为使药;其组方科学合理、配伍独到、疗效显著,有标本兼治、无毒副作用、见效快等特点;其经济和社会效益显著,生产方法简单、成本低、适合个体诊所开方治病,也适合于各级医院制剂和药厂生产中成药。
Description
技术领域
本发明涉及一种中药,特别是涉及疗效显著标本兼治的一种治疗冠心病的中药。
背景技术
冠心病是指冠状动脉粥样硬化性心脏病,为中老年人最常见的心血管疾病。冠状动脉是供应心脏血液的主要动脉,由于血管壁的粥样硬化和脂肪物质的沉积使冠状动脉狭窄和梗塞,影响血液循环,造成心肌缺血、缺氧,导致心肌损害;所以心肌损害程度与冠状动脉循环供血障碍的程度成正比。中医认为冠心病隶属于“胸痹”、“真心痛”的范畴,胸阳不振,气机闭塞则胸闷、胸痛;同时因胸中脏腑失却阳气的温煦,致阴寒内盛,阳气阻滞则津液不能运化输布,易生痰浊,痰浊寒气交阻,致血脉不通,形成瘀血;瘀血形成时胸痛更加剧烈,甚则胸痛彻背。随着年龄的增长,冠心病患者脏气功能渐退,或未老而肾亏,命门火衰,不能温煦各脏腑,导致阳衰气滞,血行不畅,发生气虚血瘀;或肾阴亏乏,不能滋养脏腑之阴,也可导致阴虚血瘀。由于胸阳不足,阴寒之邪乘虚侵袭,寒凝气滞,痹阻胸阳,心脏不通发为胸痹,也是常见的冠心病的病因。《诸病源侯论》说:“寒气客于五脏六腑,因虚而发,上冲胸间,则为胸痹。”素嗜肥甘厚味或长期饮酒,脾胃受损,运化失常,痰浊内生,阻渴胸阳,气机示畅,发为胸痹。冠心病患者精神抑制,情志失去平衡,或过度紧张不安,思虚过度,致血行不畅,气滞血瘀,心脉瘀阻发为胸痹,这同样是常见的冠心病的病因。
现有中药对冠心病的治疗主要是活血化瘀法、宣痹通阳法、芳香温通法、调整脾胃法、益气养阴法,但以上方法往往不能有机统一,只是针对某一类型;在临床上普通医生很难区分,导致药物疗效不甚显著,而且疗程长,不易痊愈。
发明内容
鉴于祖国中医学对冠心病的病因机理的理论基础,结合现有中药对冠心病的多种治疗方法;在祖传药方的基础上,再结合发明人二十余年的临床经验;提供一种治疗冠心病的中药,可滋阴补肾,益气养血,活血化瘀,理气止痛;用于冠心病、心绞痛,早期心梗,心悸、胸闷等症。本发明组方科学合理,配伍独到,疗效显著,有标本兼治、无毒副作用、见效快等特点。
本发明治疗冠心病的中药,其特征在于按下述重量份原料药材配方制成:
三七15~25份、丹参15~25份、藏红花15~25份、人工麝香10~20份、制首乌5~15份、刺五加5~15份、酸枣仁5~15份、当归5~15份、柏子仁5~15份、白芍5~15份、西洋参5~15份、冰片2~8份。
本发明治疗冠心病的中药,原料药材配方的优选重量份是:
三七20份、丹参20份、藏红花20份、人工麝香15份、制首乌10份、刺五加10份、酸枣仁10份、当归10份、柏子仁10份、白芍10份、西洋参10份、冰片5份。
本发明治疗冠心病的中药,其剂型是口服胶囊或散剂。
本发明治疗冠心病的中药,其剂型可以是药剂学中所说的任何一种口服剂型。
本发明中各原料药材的功效如下:
三七:归肝、胃、心、肺、大肠经,具有活血降脂、软化血管、散瘀止血、消肿定痛、祛风之功效,可预防冠心病、心绞痛。
丹参:入心、肝经,具有活血散淤、通经止痛、活血通经、通利关脉、清心除烦、扩张冠状动脉、改善心肌缺血状况、降低血压、安神静心、益气养血等功效;对心烦不眠、心绞痛等病症有一定的疗效,还具有抗血小板凝聚、降低血液黏度、调节内外凝血系统的功能。
藏红花:入心、肝经,珍稀名贵,具有强大的生理活性;有镇静、祛痰、解痉、止痛、调经作用,可改善心肌供血供氧,增加冠状动脉血流;用于疏经活络、血瘀血滞、活血化瘀、散郁开结、预防和治疗脑血栓、脉管炎、心肌梗塞、血亏体虚等疾病。
人工麝香:辛温,气极香,走窜之性甚烈,芳香开窍、通闭醒神、活血通经络、扩张冠状动脉、抗心绞痛,作用与硝酸甘油近似,为醒神回苏之要药,最宜闭证神昏,无论寒闭、热闭,用之皆效;治疗温病热陷心包、痰热蒙蔽心窍,用于血瘀经闭、心腹暴痛、风寒湿痹等证;可行血中之瘀滞、通经散结止痛,治疗冠心病、心绞痛。
制首乌:归肝、心、肾经,补肝肾、益精血、养心宁神、乌须发,强筋骨,化浊降脂;用于血虚萎黄、眩晕耳呜、心悸失眠、高脂血症。
刺五加:归肝、肾、心经,扩张血管、改善大脑血量,对血压有双向调节作用,有抗疲劳、补虚弱、增强骨髓造血功能;有活血脉、祛风湿、补肝肾、久服可轻身、添精补髓、抗衰老、补虚扶弱、滋补强壮,延年益寿之功效。可补中益精、强意志、调养心脾、活血去瘀、恢复非正常低血压、改善循环系统、中枢神经系统;有益智和安神、镇静、调整心肌能力的作用,能减弱心肌缺血组织损害,促进表面细胞的再生和心肌梗塞区域的恢复。
酸枣仁:归心、脾、肝、胆经,养肝、宁心、安神、敛汗,治虚烦不眠、惊悸怔忡、烦渴、体虚自汗、盗汗,有镇静催眠、微血管扩张、宁心安神的功效。
当归:归肝、心、脾经,具有补血活血,调经止痛,之功效;主症瘕结聚、肌肤麻木、血虚诸证;可增加冠脉流量,降低冠脉阻力和心肌耗氧量,增加心排出量和心搏指数,减轻阻断冠脉时的心肌梗死范围;有抗动脉硬化、抑制血小板聚集、抗血栓作用。
柏子仁:归心、肾、大肠经,养心安神、润肠通便、止汗;用于阴血不足、血不养心的思虑过度、心脾受损、虚烦失眠、心悸怔忡、阴虚盗汗。
白芍:入肝、脾经,补血养血、平抑肝阳、敛阴收汗、补血柔肝、平肝止痛;适用于阴虚发热、自汗盗汗等症;有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌、营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、调节血糖的作用。
西洋参:归心、肺、肾经,补气补血养阴、清热生津;可抑制血小板凝聚、降低血液凝固性、抗动脉粥样硬化、促进红血球生长、增加血色素;对大脑有镇静作用,对神经中枢有中度兴奋作用;有调节血压,抗心律失常、抗心肌缺血、强化心肌收缩的能力;适用于气阴两虚、心慌气短、神倦咽干、失眠、烦躁等症;有助于高血压、冠心病、急性心肌梗塞、脑血栓等疾病的恢复。
冰片:入心、肝经,开窍醒神、散火解毒;治热闭神昏、中风痰厥惊痫、中风口噤,通诸窍、散郁火、消肿止痛。
本发明治疗冠心病的中药,其优点和有益效果:本发明用于冠心病、心绞痛,早期心梗,心悸、胸闷等症;可滋阴补肾,益气养血,活血化瘀,理气止痛;其组方符合中医辨证,方中以西洋参为君,益气生津,扶元固本;麝香为臣,温肾壮阳,益肾填精;君臣结合,具有振奋根基,固本扶元的作用;丹参为佐药,藏红花为使药,涵盖君、臣、佐、使;再用三七、刺五加、酸枣仁、当归、柏子仁、白芍等配伍;使之发挥益肾壮阳、补肺纳气、养心安神、益智健脑、活血化瘀、通络散结等多种作用;全方温凉并用,消补兼施,发挥全方位的补益、调节、治疗作用,使患者在短期内恢复健康。本发明组方科学合理、配伍独到、疗效显著,有标本兼治、无毒副作用、见效快等特点;其经济和社会效益显著,生产方法简单、成本低、适合个体诊所开方治病,也适合于各级医院制剂和药厂生产中成药。
以下进一步说明本发明的临床治疗效果:
本发明经二十余年的临床观察,选择心脏病患者100例;距服药90天统计,临床治愈45例,占45%;显效54例,占54%。;总有效率为99%,且不易复发。
其典型病例如下:
1、患者女66岁;因活动时胸痛半年多,于2010年11月就诊。2010年5月快速行走时感胸痛,呈烧灼样疼痛,向背部放射,休息2~3min后症状缓解;此后上述症状常于快速行走时出现,部位、性质、缓解方式同前。医院诊断冠心病,到我处服药半个月后,活动后心痛缓解,连续服药3个月,痊愈。
2、患者男61岁;因活动时胸痛1年多,于2009年8月就诊。2008年8月骑自行车上坡时出现胸痛,为胸骨后闷痛,休息3~5min症状缓解;此后上述症状常于劳累、活动时发作,活动耐量逐渐减低;就诊3天前于静息时出现胸骨后闷痛,舌下含服硝酸甘油0.5mg后1~2min缓解,医院诊断心绞痛。到我处服药半个月后,活动后心痛缓解,连续服药3个月,痊愈。
3、患者男65岁;因活动时胸痛1年余,后出现胸痛,为胸骨后闷痛,休息3~5min症状缓解;此后上述症状常于劳累、活动时发作,活动耐量逐渐减低,并放射至后背痛,医院诊断心绞痛。到我处服药一个月后,活动后心痛缓解,连续服药3个月,痊愈。
4、患者男40岁;心悸、气短、胸痛、胸闷月余,心电图诊断冠心病;来我处就诊,服药一周后症状减轻,一个月后症状消失;继续服用2月,半年后随访,心电图显示痊愈。
5、患者女55岁;因劳动时感胸痛,呈烧灼样疼痛,向背部放射,休息片刻后症状可缓解;此后上述症状常于劳动时出现,部位、性质、缓解方式同前,医院诊断冠心病。到我处服药一周月后,活动后心痛缓解,连续服药2个月,劳动如常,半年后随访,痊愈。
具体实施方式
为了使本技术领域的人员更好的理解本发明,下面结合实施例对本发明作进一步说明。
实施例1
取下述重量原料药材:
三七150克、丹参250克、藏红花250克、人工麝香100克、制首乌50克、刺五加150克、酸枣仁50克、当归50克、柏子仁150克、白芍50克、西洋参150克、冰片20克。
上述组份按《药剂学》中的口服中药散剂工艺制备,制成1.5克/袋的本发明治疗冠心病的中药散剂。
上述组份按《药剂学》中的口服硬胶囊剂工艺制备,制成0.375克/粒的本发明治疗冠心病的中药硬胶囊剂。
用法用量:散剂口服一次一袋,一日2次,饭后服用;胶囊剂口服一次4粒,一日2次,饭后服用;注意事项:高血压患者慎用或尊遗嘱。
本发明治疗冠心病的中药,上述组份按《药剂学》中已知方法,可以生产任何一种《药剂学》中所说的口服剂型。
实施例2
取下述重量原料药材:
三七250克、丹参150克、藏红花150克、人工麝香200克、制首乌150克、刺五加50克、酸枣仁150克、当归150克、柏子仁50克、白芍150克、西洋参50克、冰片80克。
本发明治疗冠心病的中药,上述组份的口服中药散剂和口服硬胶囊剂的制备工艺、用法用量、注意事项、与实施例1相同。
本发明治疗冠心病的中药,上述组份按《药剂学》中已知方法,可以生产任何一种《药剂学》中所说的口服剂型。
实施例3
取下述重量原料药材:
三七20克、丹参20克、藏红花20克、人工麝香15克、制首乌10克、刺五加10克、酸枣仁10克、当归10克、柏子仁10克、白芍10克、西洋参10克、冰片5克。
本发明治疗冠心病的中药,上述组份的口服中药散剂和口服硬胶囊剂的制备工艺、用法用量、注意事项、与实施例1相同。
本发明治疗冠心病的中药,上述组份按《药剂学》中已知方法,可以生产任何一种《药剂学》中所说的口服剂型。
Claims (4)
1.一种治疗冠心病的中药,其特征在于按下述重量份原料药材配方制成:
三七15~25份、丹参15~25份、藏红花15~25份、人工麝香10~20份、制首乌5~15份、刺五加5~15份、酸枣仁5~15份、当归5~15份、柏子仁5~15份、白芍5~15份、西洋参5~15份、冰片2~8份。
2.根据权利要求1所述的治疗冠心病的中药,其特征在于原料药材配方的重量份是:
三七20份、丹参20份、藏红花20份、人工麝香15份、制首乌10份、刺五加10份、酸枣仁10份、当归10份、柏子仁10份、白芍10份、西洋参10份、冰片5份。
3.根据权利要求1或2所述的治疗冠心病的中药,其特征在于:所述剂型是口服胶囊或散剂。
4.根据权利要求1或2所述的治疗冠心病的中药,其特征在于:所述剂型是药剂学中所说的任何一种口服剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330836.2A CN104906274A (zh) | 2015-06-09 | 2015-06-09 | 治疗冠心病的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330836.2A CN104906274A (zh) | 2015-06-09 | 2015-06-09 | 治疗冠心病的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104906274A true CN104906274A (zh) | 2015-09-16 |
Family
ID=54075991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510330836.2A Pending CN104906274A (zh) | 2015-06-09 | 2015-06-09 | 治疗冠心病的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104906274A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825682A (zh) * | 2015-04-22 | 2015-08-12 | 李学香 | 一种用于治疗冠心病心绞痛的中药 |
| CN107029189A (zh) * | 2017-06-09 | 2017-08-11 | 孙德成 | 治疗冠心病的中药 |
| CN112999328A (zh) * | 2019-12-04 | 2021-06-22 | 防城港济仁堂中医门诊部 | 一种治疗冠心病和心梗的中药方剂及其制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526446A (zh) * | 2012-01-13 | 2012-07-04 | 张居运 | 治疗冠心病的中药组合物及其药酒的制备方法 |
| CN103550710A (zh) * | 2013-11-14 | 2014-02-05 | 曹市里 | 一种治疗冠心病的葛根瓜蒌胸痹丸 |
-
2015
- 2015-06-09 CN CN201510330836.2A patent/CN104906274A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526446A (zh) * | 2012-01-13 | 2012-07-04 | 张居运 | 治疗冠心病的中药组合物及其药酒的制备方法 |
| CN103550710A (zh) * | 2013-11-14 | 2014-02-05 | 曹市里 | 一种治疗冠心病的葛根瓜蒌胸痹丸 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825682A (zh) * | 2015-04-22 | 2015-08-12 | 李学香 | 一种用于治疗冠心病心绞痛的中药 |
| CN107029189A (zh) * | 2017-06-09 | 2017-08-11 | 孙德成 | 治疗冠心病的中药 |
| CN112999328A (zh) * | 2019-12-04 | 2021-06-22 | 防城港济仁堂中医门诊部 | 一种治疗冠心病和心梗的中药方剂及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991816B (zh) | 一种治疗心脑血管疾病的中药制剂 | |
| CN105561214A (zh) | 一种治疗冠心病的中药组合物 | |
| CN101204553A (zh) | 一种治疗尿失禁和阳痿早泄的中药及其制备方法 | |
| CN101711853B (zh) | 一种治疗心动过缓病症的中药组合物及其制备方法 | |
| CN104906274A (zh) | 治疗冠心病的中药 | |
| CN100512852C (zh) | 一种内服治疗冠心病的中药组合物 | |
| CN102961561B (zh) | 一种治疗冠心病的中药组合物 | |
| CN101195003B (zh) | 一种治疗中风及后遗症的中成药 | |
| CN100496542C (zh) | 一种治疗痹证型颈椎病的中药复方制剂及制备方法 | |
| CN102670718A (zh) | 一种治疗心脑血管疾病的中药组合物及制备方法 | |
| CN102836338A (zh) | 一种治疗心脑血管病的中药 | |
| CN102266481B (zh) | 一种治疗慢性脑供血不足的中药制剂 | |
| CN102940809B (zh) | 一种治疗心血管疾病兼汗症的药物及其制备方法 | |
| CN103212041A (zh) | 一种治疗冠心病的中药组合物 | |
| CN103385963A (zh) | 治疗冠心病引发心绞痛的中药制剂 | |
| CN103330911B (zh) | 治疗冠心病的中药组合物粉剂及其制备方法 | |
| CN110339323A (zh) | 一种治疗心动过缓的中药组合物及其制备方法和应用 | |
| CN100594916C (zh) | 贴脐降压散 | |
| CN101797330B (zh) | 调脂通络胶囊 | |
| CN101843753B (zh) | 一种治疗心绞痛的中药 | |
| CN1088816A (zh) | 护心香通药散 | |
| CN101084947A (zh) | 柏归安神茶 | |
| CN108079073A (zh) | 一种泡脚治疗寒脚缓解足部疲劳的中药粉剂 | |
| CN106074784A (zh) | 治疗冠心病心肌缺血的中药 | |
| CN100496576C (zh) | 一种治疗心血管疾病的药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150916 |
|
| RJ01 | Rejection of invention patent application after publication |